Nick Galli

Nick brings extensive experience in corporate development, strategy and operations to his role as Chief Operating Officer. Most recently Nick was CBO at CytomX Therapeutics, where he led the execution of its multi-target collaboration with Astellas. Prior to that, he was VP, Business Development and Alliance Management at Denali Therapeutics, where he closed more than twenty deals, including strategic partnerships with Sanofi, Takeda, Genentech and F-star. Before Denali, Nick was Senior Director, Transactions at the J&J Innovation Center, as well as a member of the business development and transactional law groups at Genentech. He began his career as a corporate attorney at Skadden Arps Slate Meagher & Flom and practiced in the technology transactions group at Wilson Sonsini Goodrich & Rosati. Nick received his A.B. from Princeton and his J.D. from Georgetown. Nick is an avid table tennis player and also enjoys hiking with his rescue dog Donut.